Quick Answer
Importing FDA-regulated products into the US requires coordination between FDA and CBP (U.S. Customs and Border Protection). Food importers must file Prior Notice before arrival, maintain an FSVP program to verify foreign supplier safety, ensure foreign facilities are registered, and comply with US labeling requirements. Drugs, devices, and cosmetics each have additional product-specific requirements. Non-compliance results in automatic detention, refusal of admission, and escalating penalties.
Regulatory Authority: 21 CFR Part 1 (Prior Notice, Facility Registration); 21 CFR Part 1, Subpart L (FSVP); 19 USC §1484 (CBP Entry Requirements); Section 801 of the FD&C Act (Import Operations); FDA Regulatory Procedures Manual Chapter 9
Overview of FDA Import Compliance
The United States imports more than $200 billion worth of FDA-regulated products each year, spanning food, pharmaceuticals, medical devices, cosmetics, dietary supplements, and tobacco. FDA's import program operates under Section 801 of the Federal Food, Drug, and Cosmetic (FD&C) Act, which grants the agency authority to examine, detain, and refuse admission to any article that appears to be in violation of US law.
Import compliance is not a single regulation — it is an interconnected web of requirements administered jointly by FDA and CBP. For food imports alone, an importer must satisfy Prior Notice requirements under the Bioterrorism Act, maintain a Foreign Supplier Verification Program under FSMA, ensure the foreign facility is registered with FDA, and verify that labeling meets US standards. Failure at any single point can result in the entire shipment being detained at port.
FDA Authority
Product safety, labeling, facility registration, Prior Notice, FSVP, and import alerts
CBP Authority
Entry processing, duty collection, cargo examination, and ACE/ABI electronic filing
Joint Operations
FDA reviews entry data transmitted by CBP through the ACE system to make admissibility decisions
Key Regulatory Framework
The FDA import program is governed by several overlapping statutes and regulations. The Bioterrorism Act of 2002 established Prior Notice and facility registration requirements. FSMA (2011) added the FSVP rule, the Preventive Controls rules, and expanded FDA's authority to mandate recalls and conduct foreign inspections. The FD&C Act itself provides the baseline authority for detention and refusal of imports that appear adulterated or misbranded.
CBP's role is primarily administrative: processing entry documents, collecting duties, and physically presenting goods for FDA examination when flagged. FDA makes the final admissibility determination. Both agencies operate through the Automated Commercial Environment (ACE) system, which serves as the single electronic portal for all import data.
Prior Notice Requirements for Food Imports
Under 21 CFR Part 1, Subpart I, the FDA must receive advance notice (Prior Notice) before any food article is imported or offered for import into the United States. This requirement, established by the Bioterrorism Act of 2002, applies to all food for humans and animals, including dietary supplements, infant formula, food additives, and animal feed.
Filing Timelines by Mode of Transport
Prior Notice filing windows vary by how the shipment arrives. You may file no more than 15 days before the anticipated arrival date, and no later than the minimums below:
| Mode of Transport | Minimum Advance Notice | Maximum Advance Notice | Filing Basis |
|---|---|---|---|
| Water (Sea Freight) | 8 hours before arrival | 15 days before arrival | Arrival at port of entry |
| Air (Air Freight) | 4 hours before arrival | 15 days before arrival | Arrival at port of entry |
| Land (Truck) | 2 hours before arrival | 15 days before arrival | Arrival at port of entry |
| Rail | 4 hours before arrival | 15 days before arrival | Arrival at port of entry |
| International Mail | Before arrival at US port | 15 days before arrival | Arrival at US mail facility |
Required Data Elements
Each Prior Notice submission must include: the FDA product code, the common or market name of the food, the estimated quantity, the manufacturer and shipper information (name, address, registration number if applicable), the grower (if known), the country of origin, the anticipated arrival information, and the name of the submitter. Incomplete or inaccurate Prior Notice will result in the food being held at the port.
For a detailed walkthrough of Prior Notice filing procedures and common errors, see our Prior Notice Filing Guide and the Prior Notice Prep Tool.
Prior Notice Rejection
If Prior Notice is not filed or is filed with significant errors, FDA will refuse admission of the food article. The shipment will be held at port until a valid Prior Notice is accepted. Storage and demurrage charges accumulate daily. For perishable goods, this can mean total loss of the shipment.
FSVP: The Importer's Primary Obligation
The Foreign Supplier Verification Program (FSVP), codified at 21 CFR Part 1, Subpart L, is the cornerstone of import compliance for food products under FSMA. FSVP places the responsibility squarely on the US importer to verify that food produced by foreign suppliers meets US safety standards equivalent to the Preventive Controls or Produce Safety rules.
The FSVP importer is defined as the US owner or consignee of the food at the time of entry, or, if there is no US owner or consignee at entry, the US agent or representative of the foreign owner or consignee. This is a critical distinction: the FSVP obligation falls on the party identified as the importer in the customs entry, not the customs broker or freight forwarder.
Core FSVP Requirements
- Hazard analysis for each food and each foreign supplier
- Supplier evaluation including compliance history, inspection results, and food safety performance
- Verification activities such as on-site audits, sampling and testing, or review of supplier food safety records
- Corrective actions when a foreign supplier does not produce food meeting US requirements
- Reassessment of the FSVP program at least every 3 years or when new information arises
- Recordkeeping for at least 2 years, available to FDA within 24 hours of request
For a comprehensive walkthrough of FSVP requirements, including hazard analysis templates, supplier evaluation criteria, and verification activity planning, see our FSVP Compliance Guide.
Need help building your FSVP program?
Assurentry automates hazard analysis, supplier evaluation, and verification activity tracking for food importers.
Start My RegistrationFDA Import Alerts and Detention Without Physical Examination (DWPE)
Import alerts are FDA's primary enforcement tool for import operations. When FDA identifies a pattern of violations from a particular product, firm, or country, it publishes an import alert that authorizes field offices to detain shipments without conducting a physical examination — a process known as Detention Without Physical Examination (DWPE).
How the Import Alert System Works
Import alerts contain two key lists that determine how shipments are treated:
Red List (Detention List)
Firms, products, or countries specifically listed for DWPE. All covered shipments are automatically detained at port without physical examination. The importer bears the burden of proving the goods are not in violation.
Green List (Exemption List)
Firms that have demonstrated compliance and been exempted from the import alert. Green-listed firms' shipments may still be subject to routine surveillance, but they are not automatically detained.
Common Import Alerts
FDA maintains hundreds of active import alerts. Some of the most commonly encountered include:
- Import Alert 99-19: Detention of foods containing unsafe food additives or color additives
- Import Alert 99-33: Detention of food products due to the presence of filth
- Import Alert 16-131: Detention of aquaculture seafood from specific countries due to drug residues
- Import Alert 28-07: Detention of spices due to salmonella contamination
- Import Alert 99-08: Detention of food products for labeling violations
- Import Alert 66-40: Detention of unapproved new drugs
Getting Removed from an Import Alert
To be placed on the Green List (exempted from DWPE), an importer or foreign supplier must submit evidence to FDA demonstrating that the violation has been corrected. The required evidence varies by import alert but typically includes:
- Independent laboratory test results (from an FDA-accredited or ISO 17025-accredited lab)
- Corrective action documentation and updated standard operating procedures
- Multiple consecutive compliant shipment results
- Evidence of a successful FDA inspection or third-party audit
Use our Import Alert Checker to verify whether your products, suppliers, or countries of origin are covered by active import alerts.
DWPE Risk
Once a firm is placed on an import alert's Red List, every subsequent shipment from that firm is automatically detained — regardless of whether the individual shipment has an actual violation. Removal from the Red List can take months and requires substantial documentation. Prevention is far less costly than remediation.
Entry Process: CBP and FDA Coordination
The import entry process for FDA-regulated products follows a defined sequence that involves both CBP and FDA. Understanding this flow is essential for avoiding delays and ensuring your goods clear customs efficiently.
Step-by-Step Entry Flow
1. Pre-Arrival Filing
Prior Notice is submitted to FDA (via PNSI or ABI). Customs broker files entry documents with CBP through ACE. The importer or broker transmits the entry summary (CBP Form 3461 or electronic equivalent) identifying the goods, their value, and the applicable tariff classification.
2. FDA Screening (PREDICT)
FDA's PREDICT system (Predictive Risk-based Evaluation for Dynamic Import Compliance Targeting) automatically scores each entry line based on risk factors: product type, country of origin, manufacturer history, import alert coverage, compliance history, and seasonal risk patterns. High-risk entries are flagged for review or examination.
3. FDA Review Decision
Based on PREDICT scoring, FDA makes one of several decisions: May Proceed (release without examination), Document Review (request additional documentation), Physical Examination (field exam or sample collection), or DWPE (automatic detention under import alert).
4. Examination (If Selected)
If FDA selects the shipment for examination, a field investigator inspects the goods at port, a CFS (Container Freight Station), or an FDA laboratory. This can include visual inspection, label review, sample collection for laboratory analysis, or document review.
5. Release or Detention
If the goods pass review/examination, FDA issues a 'May Proceed' notice through ACE. If a violation is found, FDA issues a Notice of Detention and Hearing, giving the importer an opportunity to present evidence. Unresolved detentions result in refusal of admission.
6. Post-Release Obligations
After release, the importer must maintain FSVP records, complete customs entry liquidation, and respond to any post-entry FDA inquiries. FDA can conduct follow-up inspections of the importer's FSVP records at any time.
ACE and the Single Window
All entry data flows through CBP's Automated Commercial Environment (ACE), which serves as the government's single-window system for import and export processing. FDA receives entry data electronically through ACE and transmits admissibility decisions back through the same system. Importers and customs brokers interact with ACE through the Automated Broker Interface (ABI) or the ACE Secure Data Portal.
Country-Specific Import Requirements
While FDA requirements apply uniformly regardless of country of origin, practical compliance considerations vary significantly by source country. Import alert coverage, FDA foreign inspection activity, bilateral agreements, and product mix all affect the risk profile of imports from different countries.
China
Key Products: Seafood, canned food, spices, dietary supplements, pet food, medical devices
High import alert coverage (IA 16-131 for aquaculture drugs, IA 99-19 for unapproved additives). Decree 248/249 registration required for food exports. FDA foreign office in Beijing, Shanghai, and Guangzhou conducts inspections.
India
Key Products: Generic drugs (API and finished dosage), spices, basmati rice, sesame, dietary supplements
Active FDA inspections at drug manufacturing sites. Import alerts for salmonella in spices (IA 28-07). Significant pharmaceutical API supplier — requires drug establishment registration and listing.
Mexico
Key Products: Fresh produce, avocados, peppers, beer, tequila, confectionery, medical devices
High-volume land border crossings at Laredo, Nogales, and Otay Mesa. 2-hour Prior Notice minimum for land shipments. Produce Safety Rule applies to fresh fruits and vegetables. USMCA trade agreement considerations.
EU Member States
Key Products: Cheese, wine, olive oil, chocolate, pharmaceuticals, medical devices, cosmetics
Generally lower import alert coverage due to robust domestic regulatory systems. Mutual Recognition Agreement for pharmaceutical GMP inspections. EU CE marking does not replace FDA device requirements — separate 510(k) or registration still required.
Japan
Key Products: Seafood, snack foods, beverages, medical devices, pharmaceuticals, cosmetics
Strong regulatory alignment with FDA. Lower import alert rates. Japanese GMP standards are generally recognized. Medical device imports require both FDA registration and compliance with QSR (21 CFR Part 820).
South Korea
Key Products: Kimchi, noodles, beverages, cosmetics (K-beauty), medical devices, electronics
Growing cosmetic export market — MoCRA registration required. K-beauty products must meet FDA labeling and ingredient requirements. MFDS (Korean FDA) standards differ from US requirements for color additives.
Brazil
Key Products: Coffee, juice concentrates, beef jerky, açaí, sugar, ethanol, medical devices
ANVISA-regulated products may still face FDA scrutiny. Import alerts for mycotoxins in Brazil nuts. Juice products subject to HACCP requirements under 21 CFR Part 120. USDA jurisdiction for fresh meat products.
Canada
Key Products: Maple syrup, canola oil, seafood, pharmaceuticals, medical devices, cannabis-derived products
2-hour Prior Notice minimum for land shipments. USMCA trade provisions apply. Canadian drug products still require full FDA registration and NDC listing. Cannabis-derived products face strict FDA import restrictions regardless of Canadian legality.
For detailed country-specific export guides, see our guides for exporting from China, India, Mexico, South Korea, and Brazil.
Labeling Requirements for Imported Products
All imported products must comply with the same labeling requirements as domestically produced goods. Labeling violations are one of the most common causes of import detention, and many violations are easily preventable with proper review before shipment.
Food Labeling Requirements
- Nutrition Facts panel compliant with 21 CFR 101.9 format and content requirements
- Ingredient list in descending order of predominance, using common or usual names
- Allergen declaration per FALCPA (Food Allergen Labeling and Consumer Protection Act) for the 9 major allergens
- Net quantity in both metric and US customary units
- Name and address of the manufacturer, packer, or distributor
- Country of origin as required by customs regulations (19 CFR Part 134)
- English language requirement for all mandatory label elements
Drug and Device Labeling
Imported drugs must carry labeling that meets 21 CFR Part 201 requirements, including the Drug Facts panel for OTC products, adequate directions for use, and the NDC number. Medical devices must include the device name, intended use, manufacturer information, and any required warnings. UDI (Unique Device Identification) labeling applies to most devices under 21 CFR Part 801, Subpart B.
Cosmetic Labeling
Imported cosmetics must comply with 21 CFR Parts 701 and 740, including ingredient declaration using INCI names, net quantity, warning statements where required, and distributor name and address. Under MoCRA, cosmetic products with known safety concerns face additional labeling scrutiny.
Import Compliance for Drugs, Devices, and Cosmetics
While food imports receive the most attention due to FSMA and FSVP, drugs, medical devices, and cosmetics each have their own distinct import compliance requirements.
Drug Import Requirements
Drug Establishment Registration
Foreign drug manufacturers must register annually with FDA under 21 CFR Part 207. Registration must be renewed between October 1 and December 31 each year.
Drug Listing with NDC
Each drug product must be listed with FDA, generating a unique National Drug Code (NDC). The NDC appears on all drug labels and is required for ACE entry filing.
cGMP Compliance
Foreign drug manufacturers must comply with current Good Manufacturing Practice regulations (21 CFR Parts 210-211). FDA conducts foreign inspections and issues Form 483 observations for violations.
US Agent Designation
Foreign drug establishments must designate a US Agent who serves as the communication link between the facility and FDA.
Medical Device Import Requirements
Device Establishment Registration
Foreign device manufacturers must register with FDA annually under 21 CFR Part 807. Registration must be completed between October 1 and December 31.
Device Listing
Each device must be listed with FDA, including the product code, proprietary name, and the establishment where it is manufactured.
Premarket Authorization
Depending on device classification, a 510(k) clearance, De Novo classification, or PMA approval may be required before the device can be imported. Class I exempt devices still require registration and listing.
QSR/cGMP Compliance
Foreign device manufacturers must comply with the Quality System Regulation (21 CFR Part 820). FDA conducts foreign inspections to verify QSR compliance.
UDI Requirements
Most devices must carry a Unique Device Identifier on their label and packaging. UDI data must be submitted to FDA's GUDID database.
Cosmetic Import Requirements (MoCRA)
Under the Modernization of Cosmetics Regulation Act (MoCRA), effective December 29, 2023, cosmetic imports face new regulatory requirements:
- Facility Registration: Foreign cosmetic manufacturing facilities must register with FDA through the Cosmetics Direct portal
- Product Listing: Each cosmetic product must be listed with FDA, including ingredient information
- Adverse Event Reporting: Serious adverse events must be reported to FDA within 15 business days
- Safety Substantiation: The responsible person must have adequate data to substantiate product safety
- Labeling Compliance: Full ingredient declaration using INCI nomenclature, fragrance allergen disclosure requirements
For more on cosmetic import compliance, see our MoCRA Compliance Guide and our US Agent Requirements Guide.
Importing drugs, devices, or cosmetics?
Assurentry handles FDA registration, product listing, and US Agent designation across all product categories.
Start My RegistrationCommon Import Violations and Penalties
FDA import violations range from administrative issues like Prior Notice errors to substantive safety violations like adulteration. The severity of the enforcement response depends on the type of violation, the product category, the importer's compliance history, and whether the violation poses a public health risk.
| Violation | Frequency | Penalty / Consequence | Enforcement |
|---|---|---|---|
| No Prior Notice filing | Very Common | Automatic refusal of admission; shipment held at port | Refusal / Hold |
| Unregistered foreign facility | Common | Food held and refused; facility cannot export to US until registered | Refusal / Import Alert |
| No FSVP program | Common | Warning letter to importer; future shipments subject to detention | Warning Letter / DWPE |
| Adulteration (filth, contamination) | Moderate | Detention, refusal, possible seizure; import alert placement | DWPE / Seizure |
| Misbranding (labeling violations) | Very Common | Detention; may allow reconditioning with corrected labels | Detention / Reconditioning |
| Unapproved food/color additives | Moderate | Automatic DWPE under import alert; refusal of admission | DWPE / Refusal |
| Unapproved new drug | Moderate | Refusal, seizure, criminal prosecution for repeat offenders | Refusal / Criminal |
| Unregistered medical device | Less Common | Detention and refusal; device cannot enter US commerce | Refusal / Import Alert |
Escalating Enforcement
FDA enforcement typically follows an escalation pattern. A first violation may result in a warning letter or detention with the opportunity to recondition. Repeat violations lead to import alerts and DWPE coverage, which affects all future shipments. Serious or willful violations can result in injunctions, seizures, civil money penalties (up to $10,000 per violation for individuals, $1,000,000 per violation for companies under certain provisions), and criminal prosecution.
Cost of Non-Compliance
Beyond FDA penalties, import violations carry significant indirect costs: port storage fees ($150-500 per day), demurrage charges ($200-400 per container per day), product spoilage for perishable goods, re-export shipping costs, loss of customer relationships, and potential liability for products that reach consumers. A single detained container can cost $10,000-50,000 in direct expenses before accounting for lost revenue.
Building an Import Compliance Program
A robust import compliance program addresses all regulatory requirements proactively, rather than reacting to violations after they occur. The following checklist covers the essential elements of a comprehensive import compliance program for FDA-regulated products.
Import Compliance Checklist
Identify FDA product classification (food, drug, device, cosmetic, dietary supplement)
Register all foreign manufacturing facilities with FDA
Designate a US Agent for each foreign facility
Obtain necessary product-specific identifiers (NDC, product codes, device listing numbers)
Establish FSVP program for all food imports (hazard analysis, supplier evaluation, verification activities)
Set up Prior Notice filing workflow with customs broker
Verify labeling compliance for English-language requirements
Monitor FDA Import Alert Library for your products, suppliers, and countries
Establish procedures for detention response (hearing requests, evidence gathering)
Maintain records for FDA inspection (FSVP records available within 24 hours of request)
Coordinate with customs broker on ACE/ABI entry filing procedures
Conduct periodic internal audits of import compliance program
Train staff on FDA and CBP requirements for your product categories
Establish corrective action procedures for import violations
Organizational Responsibilities
Effective import compliance requires clear assignment of responsibilities. Designate a compliance manager responsible for maintaining the FSVP program, monitoring import alerts, and coordinating with customs brokers. Establish SOPs for Prior Notice filing, detention response, label review, and supplier qualification. Document all processes and maintain records that can be produced within 24 hours of an FDA request.
Importers should also consider engaging qualified third-party resources for specialized tasks such as laboratory testing, foreign facility audits, and regulatory consulting. GFSI-benchmarked certifications (SQF, BRC, FSSC 22000) from foreign suppliers can support — but not replace — FSVP verification activities.
How Assurentry Streamlines Import Compliance
Assurentry provides an integrated platform that addresses the full spectrum of FDA import compliance requirements. Rather than managing Prior Notice, FSVP, facility registration, and import alert monitoring as separate workflows, Assurentry consolidates these into a single compliance dashboard.
Prior Notice Automation
Automated Prior Notice filing with pre-validated product codes, timing calculations, and confirmation tracking. Integrates with ACE/ABI for seamless customs coordination.
FSVP Program Management
Digital hazard analysis templates, supplier evaluation workflows, verification activity scheduling, and automated recordkeeping that meets FDA's 24-hour access requirement.
Import Alert Monitoring
Real-time monitoring of FDA's Import Alert Library. Automated notifications when your products, suppliers, or source countries are added to or removed from import alerts.
Facility Registration
Manage FDA registration for food facilities, drug establishments, device establishments, and cosmetic facilities from a single platform. Automated renewal reminders.
Labeling Review
Pre-shipment label review against FDA requirements for food, drug, device, and cosmetic labeling. Catch misbranding violations before goods arrive at port.
US Agent Services
Dedicated US Agent designation for foreign facilities across all product categories. Assurentry serves as your communication link with FDA.
Explore our Food Import Industry Page for a detailed overview of how Assurentry supports food importers, or see our US Agent Guide for information about US Agent requirements for foreign facilities.
Ready to simplify your import compliance?
Assurentry handles Prior Notice, FSVP, registration, and import alert monitoring in one platform.
Start My RegistrationFrequently Asked Questions
What federal agencies regulate food imports into the United States?▾
What is Prior Notice and when must it be filed?▾
What is FSVP and who must comply?▾
What is Detention Without Physical Examination (DWPE)?▾
How do I get my firm or product removed from an FDA import alert?▾
What labeling requirements apply to imported food products?▾
Do imported drugs require NDC numbers?▾
What are the penalties for FDA import violations?▾
Does MoCRA affect cosmetic imports?▾
Can Assurentry help with import compliance across multiple product categories?▾
Stop reading. Start executing.
Assurentry acts as a technical translation layer. You provide basic business info, and we automatically generate and file the exact electronic submissions required by the FDA.
Automate compliance100% FDA Acceptance Guaranteed